Add like
Add dislike
Add to saved papers

Long-term results of alumina-on-alumina hip arthroplasty for osteonecrosis.

Alumina-on-alumina bearings in THR may, in theory, provide an effective answer to osteolysis in young patients with ON of the femoral head. The purpose of this retrospective study was to report the long-term results of a series of 52 consecutive alumina THAs (41 patients) done for ON. The mean age of the patients at surgery was 41 years (range, 22-79 years). Cemented femoral stems with a 32-mm alumina head were used. Plain alumina cups were used and were either cemented (39 hips) or press-fit (13 hips). No patients were lost to followup. Sixteen hips have been revised. Aseptic loosening of the socket was the main cause of failure. At an average 16-year followup (range, 11-23.65 years), 26 hips were rated excellent and one hip was rated good. No osteolysis was observed and wear was undetectable. If revision for aseptic loosening was the end point, the rate of survival was 88.5% at 10 years for the socket and 100% at 10 years for the stem. With the alumina-on-alumina hip replacement done for ON, absence of osteolysis can be expected for as many as 24 years after the operation. New methods of socket fixation now are being explored.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app